IMB's latest news, explainers and more

 


Electric caterpillar sparks new venom discoveries

Read more

Get the latest research to your inbox

Subscribe
 

  • A $2.3M grant from Australian Cancer Research Foundation (ACRF) is being awarded to UQ IMB today to establish the new ACRF Cancer Ultrastructure and Function Facility (CUFF). The nation-leading facility will provide cutting-edge imaging capabilities for tracking and visualising cancer.
  • Join us for Superbugs at the Olympics, a free community event hosted by the IMB Centre for Superbug Solutions during Antibiotic Awareness Week.
  • Researchers from IMB have won first and third prize at Brisbane’s 2016 HealthHack, held 14-16 October at River City Labs. The winning team, Superfriends Against Superbugs, developed an app to track and map the presence of antibiotic-resistant bacteria and rapidly alert clinicians, so they can limit the spread of bacteria and fight an outbreak in real-time.
  • In a world-first, IMB's Professor Rob Capon and his team are working with industry and the community to implement a discovery that turns cane toads’ own toxin against them, with real potential to eradicate this long-term pest.
  • By creating the world’s first molecule bank, IMB scientists are working with industry and institutional partners to crowdsource antibiotic compounds, aiming to seek out new antibiotics and prevent the proliferation of drug-resistant superbugs.
  • A future where no children suffer deadly brain tumours may be within reach, thanks to the vision of a team of researchers from UQ and generous funding from The Kids’ Cancer Project. This funding will enable IMB postdoctoral researcher Dr Laura Genovesi to develop better treatments – and eventually cures – for these devastating conditions.
  • IMB researchers have been awarded $4.5 million by the Australian Research Council to lead a range of groundbreaking discovery research projects. The ARC announced funding of more than $37 million today for UQ projects spanning fields as diverse as humanities, behavioural science, biomedicine and frontier technologies.
  • Protagonist Therapeutics, a clinical-stage biopharmaceutical company founded on IMB research, has won Australian Company of the Year at the AusBiotech Industry Excellence Awards.
  • IMB research has contributed to UQ's top ranking in the Nature Index 2016 Australia and New Zealand.

Pages

Strawberry DNA extraction activity

Extract and view DNA from a strawberry using common household ingredients.

Get started

 

The Edge: Infection

The latest research and discovery

We are tackling the problem of drug-resistant bacteria through developing new diagnostics and treatments, and by empowering the community with knowledge on how to fight back against the threat of superbugs.

 View the latest issue
 Download magazine

Subscribe to our newsletter

Get the latest research straight to your inbox. 
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.

Subscribe

General enquiries

  +61 7 3346 2222
  imb@imb.uq.edu.au

Media enquiries

IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.

Support us

Donate to research
100% of donations go to the cause